Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Immunosuppressant Drugs market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Immunosuppressant Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Immunosuppressant Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
GSK
Bristol-Myers Squibb
Allergan
Veloxis Pharmaceuticals
Novartis
Roche
AbbVie
Astellas Pharma
Pfizer
Sanofi
By Type:
Calcineurin Inhibitors
MTOR Inhibitors
Anti-proliferative Agents
Steroids
Antibodies
By End-User:
Kidney
Bone Marrow
Others
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Immunosuppressant Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 Japan Immunosuppressant Drugs Market Size and Growth Rate of Calcineurin Inhibitors from 2014 to 2026
-
1.3.2 Japan Immunosuppressant Drugs Market Size and Growth Rate of MTOR Inhibitors from 2014 to 2026
-
1.3.3 Japan Immunosuppressant Drugs Market Size and Growth Rate of Anti-proliferative Agents from 2014 to 2026
-
1.3.4 Japan Immunosuppressant Drugs Market Size and Growth Rate of Steroids from 2014 to 2026
-
1.3.5 Japan Immunosuppressant Drugs Market Size and Growth Rate of Antibodies from 2014 to 2026
-
1.4 Market Segment by Application
-
1.4.1 Market Size and Growth Rate of Kidney
-
1.4.2 Market Size and Growth Rate of Bone Marrow
-
1.4.3 Market Size and Growth Rate of Others
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Immunosuppressant Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Immunosuppressant Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Immunosuppressant Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Immunosuppressant Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Immunosuppressant Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Immunosuppressant Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Immunosuppressant Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Immunosuppressant Drugs Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Immunosuppressant Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Immunosuppressant Drugs by Major Types
-
3.4.1 Japan Immunosuppressant Drugs Market Size and Growth Rate of Calcineurin Inhibitors from 2014 to 2026
-
3.4.2 Japan Immunosuppressant Drugs Market Size and Growth Rate of MTOR Inhibitors from 2014 to 2026
-
3.4.3 Japan Immunosuppressant Drugs Market Size and Growth Rate of Anti-proliferative Agents from 2014 to 2026
-
3.4.4 Japan Immunosuppressant Drugs Market Size and Growth Rate of Steroids from 2014 to 2026
-
3.4.5 Japan Immunosuppressant Drugs Market Size and Growth Rate of Antibodies from 2014 to 2026
4 Segmentation of Immunosuppressant Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Immunosuppressant Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Immunosuppressant Drugs in Kidney
-
4.4.2 Market Size and Growth Rate of Immunosuppressant Drugs in Bone Marrow
-
4.4.3 Market Size and Growth Rate of Immunosuppressant Drugs in Others
5 Market Analysis by Regions
-
5.1 Japan Immunosuppressant Drugs Production Analysis by Regions
-
5.2 Japan Immunosuppressant Drugs Consumption Analysis by Regions
6 Hokkaido Immunosuppressant Drugs Landscape Analysis
-
6.1 Hokkaido Immunosuppressant Drugs Landscape Analysis by Major Types
-
6.2 Hokkaido Immunosuppressant Drugs Landscape Analysis by Major End-Users
7 Tohoku Immunosuppressant Drugs Landscape Analysis
-
7.1 Tohoku Immunosuppressant Drugs Landscape Analysis by Major Types
-
7.2 Tohoku Immunosuppressant Drugs Landscape Analysis by Major End-Users
8 Kanto Immunosuppressant Drugs Landscape Analysis
-
8.1 Kanto Immunosuppressant Drugs Landscape Analysis by Major Types
-
8.2 Kanto Immunosuppressant Drugs Landscape Analysis by Major End-Users
9 Chubu Immunosuppressant Drugs Landscape Analysis
-
9.1 Chubu Immunosuppressant Drugs Landscape Analysis by Major Types
-
9.2 Chubu Immunosuppressant Drugs Landscape Analysis by Major End-Users
10 Kinki Immunosuppressant Drugs Landscape Analysis
-
10.1 Kinki Immunosuppressant Drugs Landscape Analysis by Major Types
-
10.2 Kinki Immunosuppressant Drugs Landscape Analysis by Major End-Users
11 Chugoku Immunosuppressant Drugs Landscape Analysis
-
11.1 Chugoku Immunosuppressant Drugs Landscape Analysis by Major Types
-
11.2 Chugoku Immunosuppressant Drugs Landscape Analysis by Major End-Users
12 Shikoku Immunosuppressant Drugs Landscape Analysis
-
12.1 Shikoku Immunosuppressant Drugs Landscape Analysis by Major Types
-
12.2 Shikoku Immunosuppressant Drugs Landscape Analysis by Major End-Users
13 Kyushu Immunosuppressant Drugs Landscape Analysis
-
13.1 Kyushu Immunosuppressant Drugs Landscape Analysis by Major Types
-
13.2 Kyushu Immunosuppressant Drugs Landscape Analysis by Major End-Users
14 Major Players Profiles
-
14.1 GSK
-
14.1.1 GSK Company Profile and Recent Development
-
14.1.2 GSK Market Performance
-
14.1.3 GSK Product and Service Introduction
-
14.2 Bristol-Myers Squibb
-
14.2.1 Bristol-Myers Squibb Company Profile and Recent Development
-
14.2.2 Bristol-Myers Squibb Market Performance
-
14.2.3 Bristol-Myers Squibb Product and Service Introduction
-
14.3 Allergan
-
14.3.1 Allergan Company Profile and Recent Development
-
14.3.2 Allergan Market Performance
-
14.3.3 Allergan Product and Service Introduction
-
14.4 Veloxis Pharmaceuticals
-
14.4.1 Veloxis Pharmaceuticals Company Profile and Recent Development
-
14.4.2 Veloxis Pharmaceuticals Market Performance
-
14.4.3 Veloxis Pharmaceuticals Product and Service Introduction
-
14.5 Novartis
-
14.5.1 Novartis Company Profile and Recent Development
-
14.5.2 Novartis Market Performance
-
14.5.3 Novartis Product and Service Introduction
-
14.6 Roche
-
14.6.1 Roche Company Profile and Recent Development
-
14.6.2 Roche Market Performance
-
14.6.3 Roche Product and Service Introduction
-
14.7 AbbVie
-
14.7.1 AbbVie Company Profile and Recent Development
-
14.7.2 AbbVie Market Performance
-
14.7.3 AbbVie Product and Service Introduction
-
14.8 Astellas Pharma
-
14.8.1 Astellas Pharma Company Profile and Recent Development
-
14.8.2 Astellas Pharma Market Performance
-
14.8.3 Astellas Pharma Product and Service Introduction
-
14.9 Pfizer
-
14.9.1 Pfizer Company Profile and Recent Development
-
14.9.2 Pfizer Market Performance
-
14.9.3 Pfizer Product and Service Introduction
-
14.10 Sanofi
-
14.10.1 Sanofi Company Profile and Recent Development
-
14.10.2 Sanofi Market Performance
-
14.10.3 Sanofi Product and Service Introduction
The List of Tables and Figures (Totals 109 Figures and 136 Tables)
-
Figure Japan Immunosuppressant Drugs Market Size and Growth Rate of Calcineurin Inhibitors from 2014 to 2026
-
Figure Japan Immunosuppressant Drugs Market Size and Growth Rate of MTOR Inhibitors from 2014 to 2026
-
Figure Japan Immunosuppressant Drugs Market Size and Growth Rate of Anti-proliferative Agents from 2014 to 2026
-
Figure Japan Immunosuppressant Drugs Market Size and Growth Rate of Steroids from 2014 to 2026
-
Figure Japan Immunosuppressant Drugs Market Size and Growth Rate of Antibodies from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
-
Figure Market Size and Growth Rate of Kidney
-
Figure Market Size and Growth Rate of Bone Marrow
-
Figure Market Size and Growth Rate of Others
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Immunosuppressant Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Immunosuppressant Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Immunosuppressant Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Immunosuppressant Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Immunosuppressant Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Immunosuppressant Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Immunosuppressant Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Immunosuppressant Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Immunosuppressant Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Immunosuppressant Drugs
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Immunosuppressant Drugs by Different Types from 2014 to 2026
-
Table Consumption Share of Immunosuppressant Drugs by Different Types from 2014 to 2026
-
Figure Japan Immunosuppressant Drugs Market Size and Growth Rate of Calcineurin Inhibitors from 2014 to 2026
-
Figure Japan Immunosuppressant Drugs Market Size and Growth Rate of MTOR Inhibitors from 2014 to 2026
-
Figure Japan Immunosuppressant Drugs Market Size and Growth Rate of Anti-proliferative Agents from 2014 to 2026
-
Figure Japan Immunosuppressant Drugs Market Size and Growth Rate of Steroids from 2014 to 2026
-
Figure Japan Immunosuppressant Drugs Market Size and Growth Rate of Antibodies from 2014 to 2026
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Immunosuppressant Drugs by Different End-Users from 2014 to 2026
-
Table Consumption Share of Immunosuppressant Drugs by Different End-Users from 2014 to 2026
-
Figure Market Size and Growth Rate of Kidney
-
Figure Market Size and Growth Rate of Bone Marrow
-
Figure Market Size and Growth Rate of Others
-
Table Japan Immunosuppressant Drugs Production by Regions
-
Table Japan Immunosuppressant Drugs Production Share by Regions
-
Figure Japan Immunosuppressant Drugs Production Share by Regions in 2014
-
Figure Japan Immunosuppressant Drugs Production Share by Regions in 2018
-
Figure Japan Immunosuppressant Drugs Production Share by Regions in 2026
-
Table Japan Immunosuppressant Drugs Consumption by Regions
-
Table Japan Immunosuppressant Drugs Consumption Share by Regions
-
Figure Japan Immunosuppressant Drugs Consumption Share by Regions in 2014
-
Figure Japan Immunosuppressant Drugs Consumption Share by Regions in 2018
-
Figure Japan Immunosuppressant Drugs Consumption Share by Regions in 2026
-
Table Hokkaido Immunosuppressant Drugs Consumption by Types from 2014 to 2026
-
Table Hokkaido Immunosuppressant Drugs Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Immunosuppressant Drugs Consumption Share by Types in 2014
-
Figure Hokkaido Immunosuppressant Drugs Consumption Share by Types in 2018
-
Figure Hokkaido Immunosuppressant Drugs Consumption Share by Types in 2026
-
Table Hokkaido Immunosuppressant Drugs Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Immunosuppressant Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Immunosuppressant Drugs Consumption Share by End-Users in 2014
-
Figure Hokkaido Immunosuppressant Drugs Consumption Share by End-Users in 2018
-
Figure Hokkaido Immunosuppressant Drugs Consumption Share by End-Users in 2026
-
Table Tohoku Immunosuppressant Drugs Consumption by Types from 2014 to 2026
-
Table Tohoku Immunosuppressant Drugs Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Immunosuppressant Drugs Consumption Share by Types in 2014
-
Figure Tohoku Immunosuppressant Drugs Consumption Share by Types in 2018
-
Figure Tohoku Immunosuppressant Drugs Consumption Share by Types in 2026
-
Table Tohoku Immunosuppressant Drugs Consumption by End-Users from 2014 to 2026
-
Table Tohoku Immunosuppressant Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Immunosuppressant Drugs Consumption Share by End-Users in 2014
-
Figure Tohoku Immunosuppressant Drugs Consumption Share by End-Users in 2018
-
Figure Tohoku Immunosuppressant Drugs Consumption Share by End-Users in 2026
-
Table Kanto Immunosuppressant Drugs Consumption by Types from 2014 to 2026
-
Table Kanto Immunosuppressant Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kanto Immunosuppressant Drugs Consumption Share by Types in 2014
-
Figure Kanto Immunosuppressant Drugs Consumption Share by Types in 2018
-
Figure Kanto Immunosuppressant Drugs Consumption Share by Types in 2026
-
Table Kanto Immunosuppressant Drugs Consumption by End-Users from 2014 to 2026
-
Table Kanto Immunosuppressant Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Immunosuppressant Drugs Consumption Share by End-Users in 2014
-
Figure Kanto Immunosuppressant Drugs Consumption Share by End-Users in 2018
-
Figure Kanto Immunosuppressant Drugs Consumption Share by End-Users in 2026
-
Table Chubu Immunosuppressant Drugs Consumption by Types from 2014 to 2026
-
Table Chubu Immunosuppressant Drugs Consumption Share by Types from 2014 to 2026
-
Figure Chubu Immunosuppressant Drugs Consumption Share by Types in 2014
-
Figure Chubu Immunosuppressant Drugs Consumption Share by Types in 2018
-
Figure Chubu Immunosuppressant Drugs Consumption Share by Types in 2026
-
Table Chubu Immunosuppressant Drugs Consumption by End-Users from 2014 to 2026
-
Table Chubu Immunosuppressant Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Immunosuppressant Drugs Consumption Share by End-Users in 2014
-
Figure Chubu Immunosuppressant Drugs Consumption Share by End-Users in 2018
-
Figure Chubu Immunosuppressant Drugs Consumption Share by End-Users in 2026
-
Table Kinki Immunosuppressant Drugs Consumption by Types from 2014 to 2026
-
Table Kinki Immunosuppressant Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kinki Immunosuppressant Drugs Consumption Share by Types in 2014
-
Figure Kinki Immunosuppressant Drugs Consumption Share by Types in 2018
-
Figure Kinki Immunosuppressant Drugs Consumption Share by Types in 2026
-
Table Kinki Immunosuppressant Drugs Consumption by End-Users from 2014 to 2026
-
Table Kinki Immunosuppressant Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Immunosuppressant Drugs Consumption Share by End-Users in 2014
-
Figure Kinki Immunosuppressant Drugs Consumption Share by End-Users in 2018
-
Figure Kinki Immunosuppressant Drugs Consumption Share by End-Users in 2026
-
Table Chugoku Immunosuppressant Drugs Consumption by Types from 2014 to 2026
-
Table Chugoku Immunosuppressant Drugs Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Immunosuppressant Drugs Consumption Share by Types in 2014
-
Figure Chugoku Immunosuppressant Drugs Consumption Share by Types in 2018
-
Figure Chugoku Immunosuppressant Drugs Consumption Share by Types in 2026
-
Table Chugoku Immunosuppressant Drugs Consumption by End-Users from 2014 to 2026
-
Table Chugoku Immunosuppressant Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Immunosuppressant Drugs Consumption Share by End-Users in 2014
-
Figure Chugoku Immunosuppressant Drugs Consumption Share by End-Users in 2018
-
Figure Chugoku Immunosuppressant Drugs Consumption Share by End-Users in 2026
-
Table Shikoku Immunosuppressant Drugs Consumption by Types from 2014 to 2026
-
Table Shikoku Immunosuppressant Drugs Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Immunosuppressant Drugs Consumption Share by Types in 2014
-
Figure Shikoku Immunosuppressant Drugs Consumption Share by Types in 2018
-
Figure Shikoku Immunosuppressant Drugs Consumption Share by Types in 2026
-
Table Shikoku Immunosuppressant Drugs Consumption by End-Users from 2014 to 2026
-
Table Shikoku Immunosuppressant Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Immunosuppressant Drugs Consumption Share by End-Users in 2014
-
Figure Shikoku Immunosuppressant Drugs Consumption Share by End-Users in 2018
-
Figure Shikoku Immunosuppressant Drugs Consumption Share by End-Users in 2026
-
Table Kyushu Immunosuppressant Drugs Consumption by Types from 2014 to 2026
-
Table Kyushu Immunosuppressant Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Immunosuppressant Drugs Consumption Share by Types in 2014
-
Figure Kyushu Immunosuppressant Drugs Consumption Share by Types in 2018
-
Figure Kyushu Immunosuppressant Drugs Consumption Share by Types in 2026
-
Table Kyushu Immunosuppressant Drugs Consumption by End-Users from 2014 to 2026
-
Table Kyushu Immunosuppressant Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Immunosuppressant Drugs Consumption Share by End-Users in 2014
-
Figure Kyushu Immunosuppressant Drugs Consumption Share by End-Users in 2018
-
Figure Kyushu Immunosuppressant Drugs Consumption Share by End-Users in 2026
-
Table Company Profile and Development Status of GSK
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK
-
Figure Sales and Growth Rate Analysis of GSK
-
Figure Revenue and Market Share Analysis of GSK
-
Table Product and Service Introduction of GSK
-
Table Company Profile and Development Status of Bristol-Myers Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
-
Table Product and Service Introduction of Bristol-Myers Squibb
-
Table Company Profile and Development Status of Allergan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan
-
Figure Sales and Growth Rate Analysis of Allergan
-
Figure Revenue and Market Share Analysis of Allergan
-
Table Product and Service Introduction of Allergan
-
Table Company Profile and Development Status of Veloxis Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Veloxis Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Veloxis Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Veloxis Pharmaceuticals
-
Table Product and Service Introduction of Veloxis Pharmaceuticals
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-
Table Company Profile and Development Status of AbbVie
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
-
Figure Sales and Growth Rate Analysis of AbbVie
-
Figure Revenue and Market Share Analysis of AbbVie
-
Table Product and Service Introduction of AbbVie
-
Table Company Profile and Development Status of Astellas Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma
-
Figure Sales and Growth Rate Analysis of Astellas Pharma
-
Figure Revenue and Market Share Analysis of Astellas Pharma
-
Table Product and Service Introduction of Astellas Pharma
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
